Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine
- PMID: 15310020
- PMCID: PMC6147811
- DOI: 10.5144/0256-4947.2004.55
Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine
Similar articles
-
Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in the Gaza Strip.J Chemother. 2002 Dec;14(6):637-8. doi: 10.1179/joc.2002.14.6.637. J Chemother. 2002. PMID: 12583559 No abstract available.
-
Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.J Antimicrob Chemother. 2007 Jul;60(1):140-4. doi: 10.1093/jac/dkm144. Epub 2007 May 11. J Antimicrob Chemother. 2007. PMID: 17496058
-
Multiresistant extended-spectrum β-lactamase producing Escherichia coli in human urine samples in Portugal.J Microbiol Immunol Infect. 2013 Oct;46(5):399-404. doi: 10.1016/j.jmii.2012.04.003. Epub 2012 Jun 21. J Microbiol Immunol Infect. 2013. PMID: 22727541 No abstract available.
-
Enterobacteriaceae that produce extended-spectrum β-lactamases and AmpC β-lactamases in the community: the tip of the iceberg?Curr Pharm Des. 2013;19(2):257-63. Curr Pharm Des. 2013. PMID: 22934977 Review.
-
Addressing the challenge of extended-spectrum beta-lactamases.Curr Opin Investig Drugs. 2009 Feb;10(2):172-80. Curr Opin Investig Drugs. 2009. PMID: 19197795 Review.
Cited by
-
Prevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda.Br Microbiol Res J. 2014 Dec;4(12):1541-1550. doi: 10.9734/BMRJ/2014/9792. Br Microbiol Res J. 2014. PMID: 26120573 Free PMC article.
-
Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital.Sci Rep. 2024 Feb 6;14(1):3022. doi: 10.1038/s41598-024-53596-x. Sci Rep. 2024. PMID: 38321071 Free PMC article.
References
-
- Yates RR. New Intervention strategies for reducing antibiotic resistance. Chest. 1999;115:24–27. - PubMed
-
- Luzzaro F, Perilli M, Amicosante G, Lombardi G, Belloni R, Zollo A, bianchi C, Toniolo A. Properties of multi-drug resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. Int J Antimicrobial Agents. 2001;17(2):131–135. - PubMed
-
- Kaye KS, Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms and clinical management. Infect Dis Clin North Am. 2000;12(2):293–319. - PubMed
-
- Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampion region of Scotland. J Hosp Infect. 1996;33:249–62. - PubMed
-
- Cormican M, Morris D, Corbett-Feeney G, Flynn J. Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection. Diag Microbiol Infect Dis. 1998;32:317–319. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical